Total Payments
$68,505
2024 Payments
$11,160
Companies
52
Transactions
1,140
Medicare Patients
1,183
Medicare Billing
$572,563
Payment Breakdown by Category
Other$39,493 (57.6%)
Food & Beverage$27,861 (40.7%)
Travel$970.67 (1.4%)
Education$180.67 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $39,493 | 21 | 57.6% |
| Food and Beverage | $27,861 | 1,111 | 40.7% |
| Travel and Lodging | $970.67 | 5 | 1.4% |
| Education | $180.67 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $33,207 | 272 | $0 (2024) |
| Allergan, Inc. | $13,180 | 34 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $3,448 | 129 | $0 (2024) |
| UCB, Inc. | $2,774 | 88 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $1,874 | 73 | $0 (2024) |
| Amgen Inc. | $1,414 | 41 | $0 (2024) |
| Lilly USA, LLC | $1,397 | 46 | $0 (2024) |
| Axsome Therapeutics, Inc. | $1,050 | 32 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $980.82 | 30 | $0 (2024) |
| PFIZER INC. | $839.37 | 52 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $11,160 | 305 | ABBVIE INC. ($5,070) |
| 2023 | $17,359 | 306 | ABBVIE INC. ($11,613) |
| 2022 | $18,191 | 285 | ABBVIE INC. ($12,326) |
| 2021 | $21,795 | 244 | Allergan, Inc. ($13,163) |
All Payment Transactions
1,140 individual payment records from CMS Open Payments — Page 1 of 46
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $44.88 | General |
| Category: Neurology | ||||||
| 12/23/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $2.46 | General |
| Category: Neurology | ||||||
| 12/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.41 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/19/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $9.71 | General |
| Category: Neurology | ||||||
| 12/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: PAIN | ||||||
| 12/18/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $3.86 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/17/2024 | LivaNova USA, Inc. | VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) | Food and Beverage | In-kind items and services | $72.25 | General |
| Category: Neurology | ||||||
| 12/17/2024 | UCB, Inc. | Zilbrysq (Drug) | Food and Beverage | In-kind items and services | $33.13 | General |
| Category: Neurology | ||||||
| 12/17/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Insomnia | ||||||
| 12/17/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $9.81 | General |
| Category: NEUROLOGY | ||||||
| 12/17/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $3.79 | General |
| Category: NEUROLOGY | ||||||
| 12/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $5.54 | General |
| Category: PAIN | ||||||
| 12/12/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $149.99 | General |
| Category: NEUROLOGY | ||||||
| 12/12/2024 | UCB, Inc. | Zilbrysq (Drug) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: Neurology | ||||||
| 12/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $32.19 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $37.79 | General |
| Category: Neuropsychiatry | ||||||
| 12/10/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $27.41 | General |
| Category: Neuroscience | ||||||
| 12/07/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $33.85 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: Neurology | ||||||
| 12/05/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Neurology | ||||||
| 12/04/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $25.33 | General |
| Category: Rare Disease | ||||||
| 12/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/03/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 325 | 33,408 | $546,210 | $204,774 |
| 2022 | 4 | 282 | 24,767 | $418,520 | $156,056 |
| 2021 | 4 | 274 | 16,548 | $299,700 | $112,987 |
| 2020 | 4 | 302 | 14,205 | $279,480 | $98,745 |
Total Patients
1,183
Total Services
88,928
Medicare Billing
$572,563
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 64 | 33,000 | $330,000 | $161,364 | 48.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 126 | 165 | $41,250 | $19,038 | 46.2% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 62 | 162 | $162,000 | $18,027 | 11.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 73 | 81 | $12,960 | $6,345 | 49.0% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 49 | 24,400 | $244,000 | $116,918 | 47.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 105 | 148 | $37,000 | $17,695 | 47.8% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 49 | 122 | $122,000 | $13,912 | 11.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 79 | 97 | $15,520 | $7,531 | 48.5% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 29 | 16,200 | $162,000 | $76,485 | 47.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 111 | 146 | $36,500 | $18,966 | 52.0% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Office | 2021 | 30 | 82 | $82,000 | $9,311 | 11.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 104 | 120 | $19,200 | $8,225 | 42.8% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2020 | 27 | 13,800 | $138,000 | $64,254 | 46.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 146 | 208 | $52,000 | $18,798 | 36.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 102 | 128 | $20,480 | $8,148 | 39.8% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Office | 2020 | 27 | 69 | $69,000 | $7,545 | 10.9% |
About Sally Decastro-Tilsen, P.A
Sally Decastro-Tilsen, P.A is a Physician Assistant healthcare provider based in Newport Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/22/2008. The National Provider Identifier (NPI) number assigned to this provider is 1023282019.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sally Decastro-Tilsen, P.A has received a total of $68,505 in payments from pharmaceutical and medical device companies, with $11,160 received in 2024. These payments were reported across 1,140 transactions from 52 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($39,493).
As a Medicare-enrolled provider, Decastro-Tilsen has provided services to 1,183 Medicare beneficiaries, totaling 88,928 services with total Medicare billing of $572,563. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Other Specialties Medical
- Location Newport Beach, CA
- Active Since 04/22/2008
- Last Updated 04/22/2008
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1023282019
Products in Payments
- BOTOX (Biological) $22,911
- UBRELVY (Drug) $15,160
- QULIPTA (Drug) $8,050
- NURTEC ODT (Drug) $1,822
- INGREZZA (Drug) $1,665
- Austedo XR (Drug) $1,619
- Aimovig (Biological) $1,414
- AJOVY (Biological) $1,283
- EMGALITY (Drug) $1,192
- Rystiggo (Drug) $1,066
- Briviact (Drug) $1,041
- Auvelity (Drug) $965.15
- ULTOMIRIS (Biological) $602.83
- VYEPTI (Biological) $469.90
- AUSTEDO (Drug) $435.34
- SPRAVATO (Drug) $403.09
- QUVIVIQ (Drug) $402.92
- TOSYMRA (Drug) $371.91
- ZEMBRACE SYMTOUCH (Drug) $357.69
- Leqembi (Drug) $334.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Newport Beach
Chelsea Vilicich, Pa-C, PA-C
Physician Assistant — Payments: $14,524
Physician Assistant $14,524
Almira Dukovic, Pa-C, PA-C
Physician Assistant — Payments: $14,439
Physician Assistant $14,439
Danichi Yoshida, Pa-C, PA-C
Physician Assistant — Payments: $11,607
Physician Assistant $11,607
Gina Duel, Ms Pac, MS PAC
Physician Assistant — Payments: $11,286
Physician Assistant $11,286
Elizabeth Cortes
Physician Assistant — Payments: $9,359
Physician Assistant $9,359
Mr. Max Kupferman, Pa-C, PA-C
Physician Assistant — Payments: $8,726
Physician Assistant $8,726